A coalition of environmental, consumer, and fishing organizations on Thursday filed a lawsuit against the U.S. Food and Drug Administration (FDA) for approving the first-ever genetically engineered (GE) animal for commercial sale and consumption—an Atlantic salmon, known colloquially as the “Frankenfish.”
The lawsuit (pdf), filed by the Center for Food Safety, Food and Water Watch, Friends of the Earth, Earthjustice, and other groups, states that the FDA does not have the authority to regulate GE animals and that approving the salmon paves the way for other GE fish, as well as farm animals like chickens, cows, and pigs, which the coalition says are currently in development.
The administration has previously claimed it did have the power, under the 1938 Federal Food, Drug, and Cosmetic Act, which was crafted to ensure safety of veterinary drugs administered to treat disease in livestock.
“FDA’s decision is as unlawful as it is irresponsible,” said George Kimbrell, senior attorney at the Center for Food Safety and one of the attorneys for the plaintiffs. “This case is about protecting our fisheries and ocean ecosystems from the foreseeable harms of the first-ever GE fish, harms FDA refused to even consider, let alone prevent.”
The salmon, which is being engineered by the biotechnology firm AquaBounty, was approved in November despite widespread outcry from advocates who said the fish pose too many risks to public health and the environment to authorize. The company plans to manufacture the eggs on Prince Edward Island in Canada, then ship them to laboratories in Panama, where they will be grown to full size.
From there, they will be sent to the U.S. for sale and consumption.
Click Here: collingwood magpies 2019 training guernsey
The journey in total comprises about 5,000 miles.
SCROLL TO CONTINUE WITH CONTENT